Sign in
8-K

Current Report

X4 Pharmaceuticals, Inc Filed Acc 0001628280-25-004254

Exit or restructuring costs · Regulation FD disclosure

  • Item 2.05 Costs associated with exit or disposal activities
  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Loading xfor-20250206.htm…